Turning Vaccination Programs Into a Profit Engine

The landscape of independent pharmacy is shifting rapidly, and vaccination programs have emerged as a cornerstone for both patient care and financial sustainability. Mark Metzger, vice president of merchandising and preferred partners for American Associated Pharmacies, explored the strategic and economic layers of modern immunization services. With the vaccine market projected to grow from $29.5 billion today to $60 billion by 2033, the transition from a traditional dispensing model to a vaccine-focused destination is no longer just an option: It is a competitive necessity.

The Strategic Value of Immunization

Beyond the immediate administration fees, a vaccine program serves as a powerful tool for patient acquisition and retention. In 2025 alone, between 120 million and 160 million vaccines were administered nationwide, led by those for influenza and COVID-19. Providing these services keeps current customers from seeking care at big-box competitors and attracts new families into the pharmacy ecosystem.

Furthermore, data suggest a significant halo effect on OTC sales. Market basket evaluations show that patients receiving vaccines frequently purchase additional items during the same visit, for example:

• Sleep aids (eg, melatonin): Purchased over 48% of the time.
• Vitamins (eg, C and D, and zinc): Purchased 46% of the time.
• Hydration and skin care: Purchased roughly 40% of the time.
• First aid: Bandages and related items are purchased over 16% of the time.

Navigating Regulatory and Operational Hurdles

Establishing a program requires a deep dive into requirements and regulations that vary significantly by state. Key operational considerations include the following:

• Training and certification: Staff must be trained in storage, handling, injection techniques, and adverse-effect management, such as anaphylaxis.
• Technician authority: As of 2025, many states allow pharmacy technicians to administer vaccines with proper certification, though 4 states still require direct pharmacist supervision for all injections.
• Collaborative Practice Agreements (CPAs): In states where pharmacists lack independent prescribing authority, establishing relationships with local physicians for CPAs is essential to streamline the workflow.

To maximize efficiency, a proactive approach is recommended over a reactive one. This involves maintaining an active inventory, utilizing pharmacy management systems to identify eligible patients by age or health condition, and implementing digital schedulers to manage daily throughput without disrupting the standard dispensing workflow.

Maximizing Profitability Through Intelligent Purchasing

The profitability of a vaccine program is often determined at the point of purchase rather than the point of administration. Although most contracts are offered at a discount from the wholesale acquisition cost, the source of the product can drastically change the final margin.

Strategic pharmacies should evaluate several purchasing channels, including the following:

• Secondary wholesalers: Often offer competitive pricing with extended dating terms (eg, 90 days) and accept credit card payments, which can net an additional 2% to 2.25% in rebates.
• GPO and LTC contracts: Group purchasing organizations (GPOs) and long-term care GPOs offer cost-of-goods–stacked discounts that can turn traditionally low-margin brand products into profitable contributors to the bottom line.
• Primary wholesaler prebooks: Although convenient, they should be weighed against secondary market savings to ensure the pharmacy is capturing every available profit dollar.

Becoming a Vaccine Destination

To succeed long-term, a pharmacy must market itself as a vaccine destination rather than just a place that stocks vaccines. This includes proactive strategies such as "Vaccination of the Month" promotions, attaching fliers to prescription bags, and maintaining a presence in the local physician community to ensure the pharmacy is the first choice for referrals.

Although starting a program requires an investment of time and research, the ability to generate 3-figure margins on specific Medicare Advantage or commercial plans makes vaccines a vital component of a modern, sustainable pharmacy business.